Is It Time to Buy the Dip on Vertex Pharmaceuticals (VRTX) Stock?

Vertex Pharmaceuticals (VRTX) plunged after Q2 earnings and is now down 21% over the past year. The company has historically had a strong R&D...

It's Not Too Late to Buy These 2 Stocks for the Nasdaq Correction

Over the past five years, the stock market has been a rollercoaster. The S&P 500 crashed 34% in early 2020 amid the pandemic, only to roar back...

This "Orphan Drug" Biotech Could Double in Less Than Three Years

The three biggest Big Pharma "blockbuster" medicines of all time target high cholesterol (Lipitor), inflammatory diseases (Humira), and digestive...

Get Your Hands on the World's First $1 Billion Cannabis Drug

When it comes to biotech, Wall Street tends to overreact. Though there's no reason for it to be there, biotech is in the dog house, and investors...

The Secret Formula That Makes Biotech Investing Profitable

Everyone knows that you can make a lot of money investing in biotech stocks.

However, you also risk losing all your hard-earned...

Top Stocks to Watch Today: DEPO, VRTX, EXAR

The top three stocks to watch today are DEPO, VRTX, and EXAR.

Brexit has officially begun in the midst of the largest growth in global...

Pages 1 of 1